A detailed history of Lansforsakringar Fondforvaltning Ab (Publ) transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Lansforsakringar Fondforvaltning Ab (Publ) holds 280,871 shares of EW stock, worth $21.6 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
280,871
Previous 296,717 5.34%
Holding current value
$21.6 Million
Previous $22 Million 7.32%
% of portfolio
0.13%
Previous 0.13%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 14, 2025

SELL
$67.95 - $76.19 $1.08 Million - $1.21 Million
-15,846 Reduced 5.34%
280,871 $20.4 Million
Q4 2024

Apr 14, 2025

BUY
$64.54 - $75.92 $19.2 Million - $22.5 Million
296,717 New
296,717 $22 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $47.5B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Lansforsakringar Fondforvaltning Ab (Publ) Portfolio

Follow Lansforsakringar Fondforvaltning Ab (Publ) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lansforsakringar Fondforvaltning Ab (Publ), based on Form 13F filings with the SEC.

News

Stay updated on Lansforsakringar Fondforvaltning Ab (Publ) with notifications on news.